These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 30415641

  • 1. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
    Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH.
    BMC Med; 2018 Nov 12; 16(1):205. PubMed ID: 30415641
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sertraline use during pregnancy and the risk of major malformations.
    Bérard A, Zhao JP, Sheehy O.
    Am J Obstet Gynecol; 2015 Jun 12; 212(6):795.e1-795.e12. PubMed ID: 25637841
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F.
    Expert Opin Drug Saf; 2020 Dec 12; 19(12):1595-1604. PubMed ID: 33001713
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb 12; 80(1):18-27. PubMed ID: 17187388
    [Abstract] [Full Text] [Related]

  • 10. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
    Myles N, Newall H, Ward H, Large M.
    Aust N Z J Psychiatry; 2013 Nov 12; 47(11):1002-12. PubMed ID: 23761574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J.
    JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    Källén BA, Otterblad Olausson P.
    Birth Defects Res A Clin Mol Teratol; 2007 Apr 01; 79(4):301-8. PubMed ID: 17216624
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.
    N Engl J Med; 2014 Jun 19; 370(25):2397-407. PubMed ID: 24941178
    [Abstract] [Full Text] [Related]

  • 20. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Malm H, Artama M, Gissler M, Ritvanen A.
    Obstet Gynecol; 2011 Jul 19; 118(1):111-120. PubMed ID: 21646927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.